Holen Sie sich die Stockscreener-App
0.4561
5.73%
0.0247
Schlusskurs vom Vortag:
$0.4314
Offen:
$0.446
24-Stunden-Volumen:
604.50K
Relative Volume:
0.07
Marktkapitalisierung:
$469.36K
Einnahmen:
$104.00K
Nettoeinkommen (Verlust:
$-8.39M
KGV:
-0.00439
EPS:
-103.9477
Netto-Cashflow:
$-8.31M
1W Leistung:
-0.89%
1M Leistung:
-52.49%
6M Leistung:
-86.86%
1J Leistung:
-98.91%
1-Tages-Spanne:
$0.4401
$0.47
1-Wochen-Bereich:
$0.3371
$0.54
52-Wochen-Spanne:
$0.3371
$44.70
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Company Profile
Firmenname
Biodexa Pharmaceuticals Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare BDRX vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDRX
Biodexa Pharmaceuticals Plc Adr
|
0.4561 | 469.36K | 104.00K | -8.39M | -8.31M | -103.95 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-08 | Eingeleitet | Ladenburg Thalmann | Buy |
Biodexa Pharmaceuticals Plc Adr Aktie (BDRX) Neueste Nachrichten
BDRX Jumps As Biodexa Advances Phase 3 eRapa Trial - StocksToTrade
Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2026 - FinanzNachrichten.de
BDRX Stock Attracts Traders As Phase 3 Trial Crosses Key Milestone - StocksToTrade
Biodexa passes halfway mark in Phase 3 trial recruitment for FAP - Investing.com South Africa
Biodexa passes halfway mark in Phase 3 trial recruitment for FAP - Investing.com India
Biodexa passes halfway mark in Phase 3 trial recruitment for FAP - Investing.com
Result of General Meeting - Yahoo Finance
Biodexa Pharmaceuticals plc (BDRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Result of Annual General Meeting - Yahoo Finance UK
Biodexa prices $3.5 million offering with warrants - Investing.com
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants - Yahoo Finance UK
symbol__ Stock Quote Price and Forecast - CNN
Biodexa expands Serenta phase 3 trial into Canada By Investing.com - Investing.com India
Biodexa expands Serenta phase 3 trial into Canada - Investing.com
Biodexa Pharmaceuticals plc Sponsored ADR Actuals & Estimates (NASDAQ:BDRX) - tradingview.com
Postponement and Re-scheduling of Annual General Meeting - markets.businessinsider.com
Postponement and Re-scheduling of Annual General Meeting - Yahoo Finance UK
BDRX News | BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) - ChartMill
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
BeOne Medicines Ltd.Sponsored ADR (ONC) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
BDRXBiodexa Pharmaceuticals Plc ADR Latest SEC Filings - Finviz
BDRX - Finviz
Biodexa proposes share capital reorganization at June meeting - Investing.com UK
Biodexa issues letter to Shareholders - markets.businessinsider.com
Biodexa proposes share capital reorganization at June meeting By Investing.com - Investing.com Nigeria
Biodexa proposes share capital reorganization at June meeting - Investing.com
Biodexa proposes share capital reorganization at June meeting By Investing.com - Investing.com Canada
Biodexa plans to shrink 373B shares without cutting ADS stakes - Stock Titan
BDRX Stock Jumps As Biodexa ADRs Lead Biotech Rally - StocksToTrade
BDRX Stock Jumps As ADR Momentum Attracts Active Traders - timothysykes.com
Biodexa Pharmaceuticals surges on pre-market trading - Intellectia AI
BDRX - Finviz
BDRX Stock Price, Quote & Chart | BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) - ChartMill
Inventory turnover of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
What Makes Haleon PLC Sponsored ADR (HLN) a New Buy Stock - Yahoo Finance
Net income before discontinued operations of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
Book value per share of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
Biodexa Pharmaceuticals plc Sponsored ADR Cash Flow – FWB:5MP2 - TradingView — Track All Markets
Net debt of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Basic earnings per share (basic EPS) of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Price to earnings ratio of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Who's Buying or Selling Biodexa Pharmaceuticals PLC (STU:5MP2) Stock Today? - GuruFocus
Biodexa Pharmaceuticals Plc: Shareholders Board Members Managers and Company Profile | US59564R8723 - marketscreener.com
Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today? - Sahm
Why is Biodexa Pharmaceuticals (BDRX) stock skyrocketing today? - MSN
Biodexa partners with Syngene for MTX240 manufacturing By Investing.com - Investing.com Australia
171.7M Ordinary Shares resale prospectus — Biodexa (NASDAQ: BDRX) - Stock Titan
109.8M Ordinary Shares resale prospectus — Biodexa (NASDAQ: BDRX) - stocktitan.net
943.4M Ordinary Shares for Resale; Biodexa (NASDAQ: BDRX) resale filing - stocktitan.net
Finanzdaten der Biodexa Pharmaceuticals Plc Adr-Aktie (BDRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):